Animal Drugs, Feeds, and Related Products; Promazine Hydrochloride Tablets; Nitrofurazone Solution

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to remove those portions of the regulations that reflect approval of two new animal drug applications (NADA's). One NADA is held by Wyeth-Ayerst Laboratories and provides for use of promazine hydrochloride tablets. The other NADA is held by Squire Laboratories, Inc., and provides for use of nitrofurazone solution. In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of the NADA's.